New home decor,start here
COMPANY

About Us

ChironPharma leverages its cutting-edge proprietary technology platform to spearhead the development and introduction of innovative allogeneic cellular medicines. Our revolutionary therapies are intricately designed to address unmet medical needs, particularly in situations where inflammation plays a pivotal role, transcending conventional standards of care.
MORE
About Us
SERVICES

Partner

We are actively seeking partners for collaboration in the following areas：
Co-Development of Drugs
Investment in Our Clinical Trials
Additionally, we are open to exploring opportunities in:

In-Licensing
Out-Licensing
Join us in our mission to advance healthcare and make a positive impact on the world. Contact us to explore potential partnerships and together, we can drive innovation and improve lives.
MORE
LATEST NEWS

News

133318416_l.jpg
FDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-Cell Lymphoma
FDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-Cell Lymphoma
MORE
132351769_l.jpg
FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
MORE
MORE
Language